1. Pvon Pirquet C. Allergy. Munch Med Wochenschr. 1906; 30:1457–1458.
2. Custovic A, Murray C, Simpson A. Allergy and infection: understanding their relationship. Allergy. 2005; 60:Suppl 79. 10–13.
Article
3. Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, Holt BJ, Hales BJ, Walker ML, Hollams E, Bochkov YA, Grindle K, Johnston SL, Gern JE, Sly PD, Holt PG, Holt KE, Inouye M. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015; 17:704–715.
Article
4. Gelfand EW. Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implications. Curr Opin Immunol. 2012; 24:713–719.
Article
5. Holt PG, Strickland DH, Sly PD. Virus infection and allergy in the development of asthma: what is the connection? Curr Opin Allergy Clin Immunol. 2012; 12:151–157.
6. Beale J, Jayaraman A, Jackson DJ, Macintyre JD, Edwards MR, Walton RP, Zhu J, Ching YM, Shamji B, Edwards M, Westwick J, Cousins DJ, Hwang YY, McKenzie A, Johnston SL, Bartlett NW. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med. 2014; 6:256ra134.
Article
7. Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Del-Rosario Jerico, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, Johnston SL. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014; 190:1373–1382.
8. Martinez FD. The connection between early life wheezing and subsequent asthma: The viral march. Allergol Immunopathol (Madr). 2009; 37:249–251.
Article
9. Fsadni C, Fsadni P, Fava S, Montefort S. Association of prevalence of rhinitis, atopic eczema, rhinoconjunctivitis and wheezing with mortality from infectious diseases and with antibiotic susceptibility at a country level. Asia Pac Allergy. 2015; 5:145–155.
Article
10. Wang JY, Liu LF, Chen CY, Huang YW, Hsiung CA, Tsai HJ. Acetaminophen and/or antibiotic use in early life and the development of childhood allergic diseases. Int J Epidemiol. 2013; 42:1087–1099.
Article
11. Barberi S, Ciprandi G, Verduci E, D'Auria E, Poli P, Pietra B, Incorvaia C, Buttafava S, Frati F, Riva E. Effect of high-dose sublingual immunotherapy on respiratory infections in children allergic to house dust mite. Asia Pac Allergy. 2015; 5:163–169.
Article
12. Wong GW. Allergic diseases in the Asia Pacific: path into the future. Asia Pac Allergy. 2013; 3:207–208.
Article
13. Morikawa A. Think globally, act locally. Asia Pac Allergy. 2013; 3:77–78.
Article
14. Thalayasingam M, Lee BW. Allergies in Asia: are we facing an allergy epidemic? Asia Pac Allergy. 2013; 3:1–2.
Article
15. Song WJ, Faruqi S, Klaewsongkram J, Lee SE, Chang YS. Chronic cough: an Asian perspective. Part 1: Epidemiology. Asia Pac Allergy. 2015; 5:136–144.
Article
16. Kang SY, Sohn KH, Lee JO, Kim SH, Cho SH, Chang YS. Intravenous tacrolimus and cyclosporine induced anaphylaxis: what is next? Asia Pac Allergy. 2015; 5:181–186.
Article
17. Jung HS, Park CH, Park YT, Bae MA, Lee YI, Kang BJ, Jegal Y, Ahn JJ, Lee T. Gynecomastia induced by H1-antihistamine (ebastine) in a patient with idiopathic anaphylaxis. Asia Pac Allergy. 2015; 5:187–190.
Article
18. Lee HS, Song WJ, Lee JW, Cho YY, Park HK, Kang MG, Cho SH, Sohn SW. Chlorpheniramine-induced anaphylaxis diagnosed by the basophil activation test. Asia Pac Allergy. 2015; 5:177–180.